Gleevac
Generic Content-Imatinib Mesylate, Manufactured By: Novartis Pharma Stein AG,Switzerland

Gleevac is used in treating chronic myelogenous leukemia (CML), gastrointestinal stromal tumors (GISTs), leukemias and other cancers. Cancers are characterized by uncontrolled growth of cells, and leukemia is a specific type of cancer characterized by uncontrolled proliferation of white blood cells.

Available As: 100 Mg & 400 Mg.